Q81.2 is a billable ICD-10 code used to specify a medical diagnosis of epidermolysis bullosa dystrophica. The code is valid during the fiscal year 2023 from October 01, 2022 through September 30, 2023 for the submission of HIPAA-covered transactions. The code is exempt from present on admission (POA) reporting for inpatient admissions to general acute care hospitals.
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Acral dystrophic epidermolysis bullosa
- Centripetalis recessive dystrophic epidermolysis bullosa
- Dominant dystrophic epidermolysis bullosa
- Dominant dystrophic epidermolysis bullosa with absence of skin
- Dominant dystrophic epidermolysis bullosa, albopapular type
- Dystrophic epidermolysis bullosa
- Dystrophic epidermolysis bullosa inverse type
- Dystrophic epidermolysis bullosa nails only
- Generalized dystrophic epidermolysis bullosa
- Generalized recessive dystrophic epidermolysis bullosa mitis
- Generalized recessive non-mutilating dystrophic epidermolysis bullosa
- Localized dystrophic epidermolysis bullosa
- Localized recessive dystrophic epidermolysis bullosa
- Progressive recessive dystrophic epidermolysis bullosa
- Recessive dystrophic epidermolysis bullosa
- Recessive dystrophic epidermolysis bullosa non-Hallopeau Siemens type
- Severe generalized recessive dystrophic epidermolysis bullosa
- Epidermolysis Bullosa Dystrophica-. form of epidermolysis bullosa characterized by atrophy of blistered areas, severe scarring, and nail changes. it is most often present at birth or in early infancy and occurs in both autosomal dominant and recessive forms. all forms of dystrophic epidermolysis bullosa result from mutations in collagen type vii, a major component fibrils of basement membrane and epidermis.
- Epidermolysis Bullosa Dystrophica-. a genetic skin disorder caused by mutations in the type vii collagen gene (col7a1). it is characterized by the formation of blisters and scarring in the skin and mucous membranes.
- Epidermolysis Bullosa Dystrophica, Autosomal Recessive|RDEB|Recessive Dystrophic Epidermolysis Bullosa-. an autosomal recessive allelic variant of epidermolysis bullosa dystrophica caused by mutation(s) in the col7a1 gene, encoding collagen alpha-1(vii) chain.
Index to Diseases and Injuries References
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for this diagnosis code are found in the injuries and diseases index:
Present on Admission (POA)
Convert to ICD-9 Code
|Source ICD-10 Code||Target ICD-9 Code|
|Q81.2||757.39 - Skin anomaly NEC|
|Approximate Flag - The approximate mapping means there is not an exact match between the ICD-10 and ICD-9 codes and the mapped code is not a precise representation of the original code.|
Your skin is your body's largest organ. It covers and protects your body. Your skin:
- Holds body fluids in, preventing dehydration
- Keeps harmful microbes out, preventing infections
- Helps you feel things like heat, cold, and pain
- Keeps your body temperature even
- Makes vitamin D when the sun shines on it
Anything that irritates, clogs, or inflames your skin can cause symptoms such as redness, swelling, burning, and itching. Allergies, irritants, your genetic makeup, and certain diseases and immune system problems can cause rashes, hives, and other skin conditions. Many skin problems, such as acne, also affect your appearance.
NIH: National Institute of Arthritis and Musculoskeletal and Skin Diseases
[Learn More in MedlinePlus]
Dystrophic epidermolysis bullosa
Dystrophic epidermolysis bullosa is one of the major forms of a group of conditions called epidermolysis bullosa. Epidermolysis bullosa cause the skin to be very fragile and to blister easily. Blisters and skin erosions form in response to minor injury or friction, such as rubbing or scratching. The signs and symptoms of dystrophic epidermolysis bullosa vary widely among affected individuals. In mild cases, blistering may primarily affect the hands, feet, knees, and elbows. Severe cases of this condition involve widespread blistering that can lead to vision loss, scarring, and other serious medical problems.
Researchers classify dystrophic epidermolysis bullosa into major types based on the inheritance pattern and features of the condition. Although the types differ in severity, their features overlap significantly and they are caused by mutations in the same gene.
Recessive dystrophic epidermolysis bullosa severe generalized (RDEB-sev gen) is the classic form of the condition and is the most severe. Affected infants are typically born with widespread blistering and areas of missing skin, often caused by trauma that occurs during birth. Most often, blisters are present over the whole body and affect mucous membranes such as the moist lining of the mouth and digestive tract. As the blisters heal, they result in severe scarring. Scarring in the mouth and esophagus can make it difficult to chew and swallow food, leading to chronic malnutrition and slow growth. Additional complications of ongoing scarring can include fusion of the skin between the fingers and toes, loss of fingernails and toenails, joint deformities (contractures) that restrict movement, and eye inflammation leading to vision loss. Additionally, people with RDEB-sev gen have a very high risk of developing a form of skin cancer called squamous cell carcinoma in young adulthood. In these individuals, the cancer tends to be unusually aggressive and is often life-threatening.
Other types of recessive dystrophic epidermolysis bullosa fall along a spectrum referred to as RDEB-generalized and localized (RDEB-gen and -loc). These forms of the condition are somewhat less severe than RDEB-sev gen and are distinguished by the affected regions of the body. Blistering is often limited to the hands, feet, knees, and elbows in mild cases, but may be widespread in more severe cases. Rare forms affect specific regions of the body, such as the shins or the abdomen. Affected people often have malformed fingernails and toenails. The RDEB-gen and -loc types involve scarring in the areas where blisters occur, but these forms of the condition do not cause the severe scarring characteristic of RDEB-sev gen.
Another major type of this condition is known as dominant dystrophic epidermolysis bullosa (DDEB). The signs and symptoms of this condition tend to be milder than those of the recessive forms, with blistering often limited to the hands, feet, knees, and elbows. The blisters heal with scarring, but it is less severe than in recessive forms of this condition. Most affected people have malformed fingernails and toenails, and the nails may be lost over time. In the mildest cases, abnormal nails are the only sign of the condition.
[Learn More in MedlinePlus]
Epidermolysis BullosaEpidermolysis bullosa is a group of rare diseases that cause fragile skin that leads to blistering and tearing.
[Learn More in MedlinePlus]
- FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
- FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)